Michael M. Barnes
Thursday, October 25, 2018
Amgen Slashes the Price of a Promising Cholesterol Drug
The drug maker cut the list price of the drug Repatha by 60 percent in an effort to increase sales, which have been meager.
from Well https://ift.tt/2qd4jvu
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment